TR201821114A2 - Erdostei̇n i̇çeren efervesan farmasöti̇k bi̇leşi̇m - Google Patents

Erdostei̇n i̇çeren efervesan farmasöti̇k bi̇leşi̇m Download PDF

Info

Publication number
TR201821114A2
TR201821114A2 TR2018/21114A TR201821114A TR201821114A2 TR 201821114 A2 TR201821114 A2 TR 201821114A2 TR 2018/21114 A TR2018/21114 A TR 2018/21114A TR 201821114 A TR201821114 A TR 201821114A TR 201821114 A2 TR201821114 A2 TR 201821114A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical composition
efervescent
erdostein
effervescent
erdosteine
Prior art date
Application number
TR2018/21114A
Other languages
English (en)
Inventor
Koç Erhan
Aktaş Tolga
Original Assignee
Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi
Publication of TR201821114A2 publication Critical patent/TR201821114A2/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/12Mucolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Buluş, aktif etken madde olarak Erdostein ve / veya Erdostein?in farmasötik açıdan kabul edilebilir tuzları, esterleri, polimorfları, solvatları, enanatiomerleri ve / veya türevleri, 5 en az bir efervesan asit-baz çifti ve en az bir yardımcı madde içeren efervesan farmasötik bileşim ile ilgilidir.
TR2018/21114A 2017-12-31 2018-12-30 Erdostei̇n i̇çeren efervesan farmasöti̇k bi̇leşi̇m TR201821114A2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17020598.3A EP3505164A1 (en) 2017-12-31 2017-12-31 An effervescent composition comprising erdosteine

Publications (1)

Publication Number Publication Date
TR201821114A2 true TR201821114A2 (tr) 2019-07-22

Family

ID=61258113

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2018/21114A TR201821114A2 (tr) 2017-12-31 2018-12-30 Erdostei̇n i̇çeren efervesan farmasöti̇k bi̇leşi̇m

Country Status (2)

Country Link
EP (1) EP3505164A1 (tr)
TR (1) TR201821114A2 (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114727952A (zh) * 2019-10-17 2022-07-08 Isp投资有限公司 稳定的泡腾共处理赋形剂组合物及其制备方法
IT202000016816A1 (it) * 2020-07-10 2022-01-10 Edmond Pharma Srl Composizioni comprendenti composti antiossidanti come coadiuvanti nel trattamento di infezioni virali

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA963591B (en) * 1995-05-10 1996-11-19 Adcock Ingram Ltd Pharmaceutical composition
CN101181274A (zh) * 2007-11-27 2008-05-21 北京润德康医药技术有限公司 一种以头孢克肟和厄多司坦为活性成分的药用组合物及其制备方法、用途
CN101199519A (zh) * 2007-11-30 2008-06-18 北京润德康医药技术有限公司 含有环己西林或其衍生物的组合物及其制备方法
CN101214245A (zh) * 2008-01-09 2008-07-09 北京润德康医药技术有限公司 含有环己西林或其衍生物的组合物及其制备方法
CN101612154A (zh) * 2008-06-23 2009-12-30 广东肇庆星湖生物科技股份有限公司 含有匹氨西林的组合物及制备方法、用途

Also Published As

Publication number Publication date
EP3505164A1 (en) 2019-07-03

Similar Documents

Publication Publication Date Title
CO2020000145A2 (es) Carboxamidas como moduladores de los canales de sodio
MX2021014509A (es) Composiciones farmaceuticas que comprenden meloxicam.
CL2020001271A1 (es) Inhibidores de kras g12c
DOP2022000115A (es) Tetrahidrofuranos sustituidos como moduladores de canales de sodio
MA38399B2 (fr) Formulation sous forme de comprimé, utile pour traiter l'insuffisance cardiaque aiguë et l'insuffisance cardiaque chronique
CY1121554T1 (el) Παραγωγο πυρανοχρωμενυλ-φαινολης, και φαρμακευτικη συνθεση για αγωγη μεταβολικου συνδρομου ή φλεγμονωδους παθησης
EA201992116A1 (ru) Фармацевтические составы флороглюцинола и триметилфлороглюцинола
CR20190332A (es) Inhibidores selectivos de jak1
BR112018009534A2 (pt) composição farmacêutica contendo 2-{4-[n-(5,6-difenilpirazin-2-il)-n-isopropilamino]butiloxi }-n-(metilsulfonil)acetamida
TR201900680T4 (tr) CXCR3 Reseptör modülatörleri olarak hidroksialkil- piperazin türevleri.
CR20180091A (es) 5-(n-bencil-tetrahidroisoquinolin-6-il)-piridin-3-il acético como inhibidores de la replicación del vih
TR201821114A2 (tr) Erdostei̇n i̇çeren efervesan farmasöti̇k bi̇leşi̇m
CY1123527T1 (el) Αντιφυματικος παραγοντας
CY1123185T1 (el) Παραγωγα ινδολιου
BR112015032534A2 (pt) usos de composto ou de sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, composições farmacêuticas e métodos para prevenir e/ou tratar encefalopatia traumática crônica ou condição relacionada em indivíduo e para tratar indivíduo com lesão de concussão
BR112018068170A2 (pt) ácido (2s,4r)-5-(5?-cloro-2?-fluor-[1,1?-bifenil]-4-il)-2-(etoximetil)-4-(3-hidroxi-isoxazol-5-carboxamido)-2-metilpentanoico cristalino e usos dos mesmos
JOP20180071B1 (ar) استخدام مشتقات أمينو ألكيل بنزوثيازبين
TR201721700A2 (tr) Saksagli̇pti̇ni̇n ağizda dağilan formülasyonlari
BR112017014295A2 (pt) composição farmacêutica.
TR201821115A2 (tr) Montelukast ve levoseti̇ri̇zi̇n i̇çeren farmasöti̇k bi̇leşi̇m
TR201815617A2 (tr) Deksketoprofen içeren bir formülasyon.
TR201619983A2 (tr) Di̇klofenak ve eletri̇ptanin farmasöti̇k formülasyonlari
PH12016502527A1 (en) Stabilized desmopressin
UA123395U (uk) Фармацевтична композиція ністатину у формі оральної суспензії
TR201722630A2 (tr)